Efficacy of Siponimod in Managing Relapsing-Remitting Multiple Sclerosis: Insights from a Real-World Cohort Study in a Chinese Center - Top-Institutions - MDSpire

Efficacy of Siponimod in Managing Relapsing-Remitting Multiple Sclerosis: Insights from a Real-World Cohort Study in a Chinese Center

  • By

  • Hongmei Tan

  • Lei Zhou

  • Yue Gao

  • Chongbo Zhao

  • Chuanzhen Lu

  • Qiang Dong

  • Jingzi ZhangBao

  • Chao Quan

  • February 18, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurology
    • Neuroimmunology
    • Multiple Sclerosis
  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Neuroimmunology
  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Neuroimmunology
  • #4

    Huashan Hospital, Fudan University
    Huashan Hospital, Fudan University

    Shanghai, China

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
  • #5

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Neuroimmunology

Original Source(s)

Related Content